Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+20.94%
adds when stocks drop
when a holding falls −10%+
Middle response
+17.10%
steady accumulation
Rally response
-17.90%
trims into rallies
when a holding rises +10%+
Top positions · 8
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| ARGXargenx SE | $112M | 40.1% | +23.4% | 2.5 yr |
| RYTMRhythm Pharmaceuticals, | $107M | 38.3% | +64.2% | 2.5 yr |
| RVMDRevolution Medicines, In | $26M | 9.2% | +175.0% | 1.5 yr |
| IRONDisc Medicine, Inc. | $18M | 6.6% | +28.8% | 2.0 yr |
| CYTKCytokinetics, Incorporat | $12M | 4.3% | +64.0% | 2.0 yr |
| SEPNSepterna, Inc. | $2M | 0.9% | +315.0% | 1.0 yr |
| CRNXCrinetics Pharmaceutical | $1M | 0.5% | +8.3% | 0.5 yr |
| TRVITrevi Therapeutics, Inc. | $1M | 0.2% | +89.7% | 1.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+6.9pp$279M
Country
US59.9%+4.2pp
NL40.1%+2.8pp
Top 5: 98.4% · Top 10: 100.0% · Top 25: 100.0%
Winners
| Ticker | Prev $ | PnL | YoY % |
|---|---|---|---|
| RYTM | $48M | +0.03B | 64.2% |
| RVMD | $14M | +0.02B | 175.0% |
| ARGX | $68M | +0.02B | 23.4% |
| SEPN | $5M | +0.02B | 315.0% |
| IRON | $12M | +0.00B | 28.8% |
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $279M | 8 | +57.62% | +17.59% | +40.03% | -0.01B |
| 2025-12-31 | $316M | 6 | +69.52% | +17.72% | +51.80% | -0.01B |
| 2025-09-30 | $298M | 10 | +49.75% | +17.52% | +32.23% | -0.01B |
| 2025-06-30 | $215M | 8 | +28.48% | +14.94% | +13.54% | +0.02B |
| 2025-03-31 | $182M | 14 | +16.05% | +8.30% | +7.75% | -0.01B |
| 2024-12-31 | $196M | 16 | +17.00% | +24.89% | -7.88% | +0.00B |
| 2024-09-30 | $202M | 16 | +23.47% | +5.75% | +17.72% | -0.00B |
| 2024-06-30 | $166M | 16 | -1.62% | +4.38% | -6.00% | +0.02B |
| 2024-03-31 | $150M | 17 | +0.02% | +10.39% | -10.37% | +0.01B |
| 2023-12-31 | $143M | 17 | — | — | — | — |